Simplicity Wealth LLC bought a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,380 shares of the company’s stock, valued at approximately $576,000. Simplicity Wealth LLC owned 0.06% of U.S. Physical Therapy as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of USPH. Bank of America Corp DE raised its position in shares of U.S. Physical Therapy by 77.2% in the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock valued at $26,946,000 after buying an additional 138,194 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in U.S. Physical Therapy during the second quarter worth approximately $9,087,000. Schroder Investment Management Group increased its stake in U.S. Physical Therapy by 45.9% during the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after acquiring an additional 114,618 shares during the period. 4D Advisors LLC bought a new position in shares of U.S. Physical Therapy in the third quarter worth $9,344,000. Finally, First Trust Advisors LP raised its position in shares of U.S. Physical Therapy by 607.2% in the 4th quarter. First Trust Advisors LP now owns 69,834 shares of the company’s stock valued at $5,453,000 after buying an additional 59,959 shares in the last quarter.
Insider Activity at U.S. Physical Therapy
In related news, Director Peter Francis Minan bought 492 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, June 8th. The shares were acquired at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the completion of the acquisition, the director directly owned 2,923 shares of the company’s stock, valued at approximately $184,558.22. The trade was a 20.24% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 2.40% of the stock is currently owned by corporate insiders.
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.06). The company had revenue of $214.06 million for the quarter, compared to the consensus estimate of $211.36 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The firm’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.81 earnings per share. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.96 EPS for the current year.
U.S. Physical Therapy Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 21st will be paid a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, August 21st. U.S. Physical Therapy’s payout ratio is currently 1,082.35%.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. Citizens Jmp restated a “market outperform” rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, June 24th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Barrington Research boosted their price target on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Finally, Citigroup reaffirmed an “outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, August 10th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $99.50.
Read Our Latest Stock Report on USPH
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
